1704. Survival of HIV-infected patients in ICU in the era of highly active antiretroviral therapy
Session: Poster Abstract Session: HIV: HIV and ICU Outcomes
Saturday, October 10, 2015
Room: Poster Hall
  • ID week 2015 poster Turvey draft 3.pdf (346.2 kB)
  • Background:

    In the era of combination antiretroviral therapy (cART), mortality and morbidity of HIV patients has declined.  However, data suggest that intensive care unit (ICU) admission rates have not declined.  In this study, we describe the epidemiology of critically ill HIV-infected patients and identify prognostic markers for 30-day mortality.


    Data were retrospectively collected on all HIV-infected patients admitted to five intensive care units (ICUs) in Edmonton, Alberta from July 2002 to July 2014.  Univariate and multivariable (Cox proportional hazards regression) analyses were performed to identify factors associated with mortality.


    During the study period, 282 patients had 343 discrete ICU admissions.  Mean age was 44 (±10 SD), 202 (59%) were male, 203 (59%) had hepatitis C virus (HCV) coinfection, and 229 (67%) had documented polysubstance abuse.  Median CD4 count was 130 (IQR 30-300) cells/mm3and median viral load 20,500 (IQR 37-220,000) copies/mL. Only 133 (39%) patients were receiving cART while 33 (10%) were newly diagnosed in the ICU. Most common admission diagnosis was sepsis (50%) and 48% had respiratory failure. Most patients [259 (76%)] received mechanical ventilation and 169 (49%) received vasopressor support.  Care was limited in 89 (26%) patients and withdrawn in 53 (16%). Seventy-four (22%) patients died within 30 days of ICU admission.

    Correlates of 30-day mortality on univariate analysis included newly diagnosed HIV infection, APACHE II score, shock, and limitations on or withdrawal of care.  On multivariable analysis, APACHE II (adjusted hazard ratio [aHR] 1.06; 95%CI 1.02–1.09, p=0.001), care limitation (aHR 4.6; 95%CI 2.3-9.2, p<0.001) and care withdrawal (aHR 5.2; 95%CI 2.7-9.8, p<0.001) were independently associated with 30-day mortality.  Surprisingly, CD4 count and viral load were not independently associated with mortality. 


    Mortality of critically ill HIV-infected patients remains high in the cART era.  Substance abuse and HCV co-infection were common in our population.  In this young cohort, one in four patients had care limited. APACHE II score, care limitation and care withdrawal were independently associated with mortality. This suggests that HIV-positivity and degree of immune suppression may not be the chief determinants of mortality in this vulnerable population.

    Shannon L. Turvey, MD, MSc, Infectious Diseases, University of Alberta, Edmonton, AB, Canada, Sean Bagshaw, MD, MSc, Critical Care Medicine, University of Alberta, Edmonton, AB, Canada and Wendy I. Sligl, MD, MSc, FRCPC, Infectious Diseases and Critical Care Medicine, University of Alberta, Edmonton, AB, Canada


    S. L. Turvey, None

    S. Bagshaw, None

    W. I. Sligl, None

    Previous Abstract | Next Abstract >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.